CDC/ACIP [U.S.] [to 20 Nov 2021]
http://www.cdc.gov/media/index.html
https://www.cdc.gov/vaccines/acip/index.html
Latest News Releases, Announcements [Selected]
CDC Expands Eligibility for COVID-19 Booster Shots to All Adults
Friday, November 19, 2021
[See U.S. COVID Response above for detail]

ACIP Meetings
:: Agenda – November 19, 2021 pdf [COVID Boosters/Adults]
:: Presentations

MMWR News Synopsis Friday, November 19, 2021
Selected Content
:: Health Care Access and Use Among Adults with Diabetes During the COVID-19 Pandemic — United States, February–March 2021
:: Automated Digital Notification of COVID-19 Diagnoses Through Text and Email Messaging — North Carolina, December 2020–January 2021
:: Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status — Oregon and Washington, July 4–September 25, 2021
:: Impact of Hospital Strain on Excess Deaths During the COVID-19 Pandemic — United States, July 2020–July 2021

Coronavirus Disease 2019 (COVID-19)– CDC
Approximately 25 announcements/reports/data summaries.
11/19/21
CDC Expands Eligibility for COVID-19 Booster Shots to All Adults

11/19/21
Overall US COVID-19 Vaccine Distribution and Administration Update as of Fri, 19 Nov 2021 06:00:00 EST

Africa CDC [to 20 Nov 2021]
http://www.africacdc.org/
News
Press Releases
Africa CDC and CDDEP release African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes
Addis Ababa, Ethiopia, 19 November 2021– An interdisciplinary panel of infectious disease clinicians and public health experts led by the Africa Centres for Disease Control and Prevention (Africa CDC) and the Center for Disease Dynamics, Economics & Policy (CDDEP) have released a first edition of the African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes…
The week also marks two years since a unique partnership of six regional organizations was formed to push ahead on fighting AMR in Africa, involving the Tripartite Partners (the Food and Agriculture Organization of the United Nations (FAO), the World Organization for Animal Health (OIE), and the World Health Organization (WHO)), with the UN Environment Programme (UNEP) ,  the Africa Centres for Disease Control and Prevention (Africa CDC), and the African Union Inter-African Bureau for Animal Resources (AU-IBAR)..

Press Releases
Stronger governance needed to fight superbugs in Africa Antimicrobial Resistance threatens Africa’s development
Addis Ababa, Ethiopia, 17 November 2021– The leaders of six regional organizations in Africa are calling for stronger governance to fight antimicrobial resistance, or AMR, on the eve of World Antimicrobial Awareness Week (18-24 November)…
The week also marks two years since a unique partnership of six regional organizations was formed to push ahead on fighting AMR in Africa, involving the Tripartite Partners (the Food and Agriculture Organization of the United Nations (FAO), the World Organization for Animal Health (OIE), and the World Health Organization (WHO)), with the UN Environment Programme (UNEP) ,  the Africa Centres for Disease Control and Prevention (Africa CDC), and the African Union Inter-African Bureau for Animal Resources (AU-IBAR)..

China CDC http://www.chinacdc.cn/en/

National Health Commission of the People’s Republic of China [to 20 Nov 2021]
http://en.nhc.gov.cn/
News
Nov 20: Daily briefing on novel coronavirus cases in China
2021-11-20
On Nov 19, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 23 new cases of confirmed infections (20 imported cases, 6 in Shanghai municipality, 5 in Guangxi Zhuang autonomous region, 4 in Shandong province, 2 in Guangdong province, 2 in Yunnan province and 1 in Fujian province, including 1 confirmed case converting from an asymptomatic case in Guangdong; 3 indigenous cases, 2 in Dalian, Liaoning province and 1 in Jilin, Jilin province), no new cases of suspected infections, and no deaths…

National Medical Products Administration – PRC [to 20 Nov 2021]
http://english.nmpa.gov.cn/
News
COVID-19 vaccine doses administered on Chinese mainland hit 2.4b milestone
2021-11-18
More than 2.4 billion doses of COVID-19 vaccines had been administered on the Chinese mainland as of Nov 16, data from the National Health Commission showed on Nov 17.

China, US need to initiate global public health, infectious disease response cooperation mechanism: Xi
2021-11-17
President Xi Jinping on Tuesday said that China and the United States need to call for the establishment of a cooperation mechanism for global public health and communicable disease prevention and control, and promote further international exchanges and cooperation. Xi made the remarks in a virtual meeting with US President Joe Biden…

CCDC Weekly – Weekly Reports: Current Volume (3)
2021-11-19 / No. 47 WORLD ANTIBIOTIC AWARENESS WEEK ISSUE
View  PDF of this issue
:: Foreword: World Antimicrobial Awareness Week 2021 — Spread Awareness, Stop Resistance
:: Preplanned Studies: Genomic Insight into the Antimicrobial Resistance of Streptococcus Suis — Six Countries, 2011–2019
:: Preplanned Studies: Prevalence of Escherichia coli and Antibiotic Resistance in Animal-Derived Food Samples — Six Districts, Beijing, China, 2020
:: Vital Surveillances: Surveillance of Multidrug-Resistant Bacterial Infections in Non-Adult Patients — Zhejiang Province, China, 2014–2019

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

American Journal of Public Health
November 2021 111(11)
http://ajph.aphapublications.org/toc/ajph/current

EDITORIALS
An Unnecessary Gift for COVID-19 Vaccines and Therapeutics: The Medical Countermeasure Priority Review Voucher
Government, Immunization/Vaccines, Health Law
Reshma Ramachandran, Ravi Gupta and Jing Luo
111(11), pp. 1923–1926

American Journal of Public Health
November 2021 111(11)
http://ajph.aphapublications.org/toc/ajph/current

OPEN-THEMED RESEARCH
Vaccine Coverage Across the Life Course in Michigan During the COVID-19 Pandemic: January‒September 2020
Immunization/Vaccines, Epidemiology
Angela K. Shen, Cristi A. Bramer, Lynsey M. Kimmins, Robert Swanson, Patricia Vranesich and Walter Orenstein
111(11), pp. 2027–2035

Annals of Internal Medicine
November 2021 Volume 174, Issue 11
http://annals.org/aim/issue

Original Research
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy – A Randomized Controlled Trial
Jeffrey R. Curtis, MD, MS, MPH, Stacey S. Cofield, PhD, S. Louis Bridges Jr., MD, PhD, John Bassler, MS, … et al.

Annals of Internal Medicine
November 2021 Volume 174, Issue 11
http://annals.org/aim/issue

What Will It Take to End HIV in the United States? A Comprehensive, Local-Level Modeling Study
Anthony Todd Fojo, MD, MHS, Melissa Schnure, ScM, Parastu Kasaie, PhD, … et al.

Pages:1542–1553

Annals of Internal Medicine
November 2021 Volume 174, Issue 11
http://annals.org/aim/issue

Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
A Prospective Cohort Study

FREE
Parakkal Deepak, MBBS, MS, Wooseob Kim, PhD, Michael A. Paley, MD, PhD, Monica Yang, MD, … et al.
Pages:1572–1585

Annals of Internal Medicine
November 2021 Volume 174, Issue 11
http://annals.org/aim/issue

Population Immunity Against COVID-19 in the United States
FREE

Seyed M. Moghadas, PhD, Pratha Sah, PhD, Affan Shoukat, PhD, Lauren Ancel Meyers, PhD, … et al.
Pages:1586–1591

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 20 Nov 2021)

Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries
Model-based estimates of measles burden and the impact of measles-containing vaccine (MCV) are crucial for global health priority setting. Recently, evidence from systematic reviews and database analyses have …
Authors: Han Fu, Kaja Abbas, Petra Klepac, Kevin van Zandvoort, Hira Tanvir, Allison Portnoy and Mark Jit
Citation: BMC Medicine 2021 19:281
Content type: Research article
Published on: 17 November 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 20 Nov 2021)

Community perceptions of vaccination among influential stakeholders: qualitative research in rural India
In India and other low- and middle-income countries, multiple family and community members are influential in caregivers’ perceptions of vaccination. Existing literature indicates the primary caregiver, typica…
Authors: Baldeep K. Dhaliwal, Riti Chandrashekhar, Ananya Rattani, Rajeev Seth, Svea Closser, Anika Jain, David E. Bloom and Anita Shet
Citation: BMC Public Health 2021 21:2122
Content type: Research article
Published on: 18 November 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 20 Nov 2021)

Knowledge of mothers regarding children’s vaccinations in Greece: an online cross-sectional study
One of the main reasons that influence parental choice to postpone or avoid children’s vaccination is insufficient knowledge. Mothers’ knowledge can be considered as an important factor when determining childc…
Authors: Konstantinos Giannakou, Maria Kyprianidou, Andria Hadjikou, Georgia Fakonti, Galatia Photiou, Eleana Tzira and Alexandros Heraclides
Citation: BMC Public Health 2021 21:2119
Content type: Research
Published on: 18 November 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 20 Nov 2021)

COVID-19 vaccination acceptance among Syrian population: a nationwide cross-sectional study
Severe Acute Respiratory Syndrome Coronavirus 2 continues to spread globally and in the absence of an effective treatment, the vaccine remains the best hope for controlling this disease. In this study, we seek…
Authors: Mosa Shibani, Mhd Amin Alzabibi, Abd El-Fattah Mouhandes, Tamim Alsuliman, Angie Mouki, Hlma Ismail, Shahd Alhayk, Ahmad Abdulateef Rmman, Marah Mansour, Marah Marrawi, Nawras Alhalabi, Mhd Baraa Habib, Mhd Kutaiba Albuni, Ahmad Al-Moujahed and Bisher Sawaf
Citation: BMC Public Health 2021 21:2117
Content type: Research
Published on: 18 November 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 20 Nov 2021)

COVID19 vaccine intentions in South Africa: health communication strategy to address vaccine hesitancy
Vaccine hesitancy is emerging as a significant challenge in many parts of the world in the fight against the COVID19 pandemic. The continued infection amongst the unvaccinated can lead to a heightened risk of …
Authors: Umakrishnan Kollamparambil, Adeola Oyenubi and Chijioke Nwosu
Citation: BMC Public Health 2021 21:2113
Content type: Research
Published on: 17 November 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 20 Nov 2021)

Racial differences in institutional trust and COVID-19 vaccine hesitancy and refusal
Previous research has indicated that demographic differences affect COVID-19 vaccination rates. Trust, in both the vaccine itself and institutional trust, is one possible factor. The present study examines rac…
Authors: Anisah B. Bagasra, Sara Doan and Christopher T. Allen
Citation: BMC Public Health 2021 21:2104
Content type: Research
Published on: 16 November 2021

Clinical Therapeutics
October 2021 Volume 43 Issue 10 p1627-1808
http://www.clinicaltherapeutics.com/current

CONVERSATIONS WITH THE EDITORS
Conversations With the Editors: The Emergence of Variants Amid Population-Wide SARS-CoV-2 Vaccination Efforts: How Much Should We Worry?
Egon Ozer, Larry K. Kociolek, Ravi Jhaveri
Published online: July 25, 2021
p1630-1635

Clinical Therapeutics
October 2021 Volume 43 Issue 10 p1627-1808
http://www.clinicaltherapeutics.com/current

Commentary
Behavioral Economics as a Model to Improve Adolescent and Adult Vaccination
Rachel Caskey
Published online: August 03, 2021
p1649-1653
Despite that fact that the first scientifically based smallpox vaccine was developed in the late 1700s, in 2021 we struggle to fully vaccinate adolescents and adults in the United States. Decades of scientific data support the efficacy and tolerability of vaccines in general, yet vaccine hesitancy remains common. Fear sits much deeper than logic within the human psyche, especially when it comes to vaccine decision making. The complexities of human psychology and decision making are the footings of vaccine hesitancy and yet may also provide an opportunity to shift vaccination behavior.

Ethics & Human Research
Volume 43, Issue 6 Pages: 1-48 November–December 2021
https://onlinelibrary.wiley.com/toc/25782363/current

Articles
Physician Perspectives on Including Pregnant Women in Covid-19 Clinical Trials: Time for a Paradigm Change
Marie-Julie Trahan, Annabelle Cumyn, Matthew P. Cheng, Emily G. McDonald, Stephen E. Lapinsky, Nick Daneman, Haim A. Abenhaim, Isabelle Malhamé
Pages: 19-27
First Published: 26 October 2021

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/localisation-and-local-humanitarian-action/

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 20 Nov 2021]

Scoping Review
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
To date, coronavirus disease 2019 (COVID-19) becomes increasingly fierce due to the emergence of variants. Rapid herd immunity through vaccination is needed to block the mutation and prevent the emergence of variants that can completely escape the immune surveillance. We aimed to systematically evaluate the effectiveness and safety of COVID-19 vaccines in the real world and to establish a reliable evidence-based basis for the actual protective effect of the COVID-19 vaccines, especially in the ensuing waves of infections dominated by variants.
Authors: Qiao Liu, Chenyuan Qin, Min Liu and Jue Liu
14 November 2021

JAMA
November 16, 2021, Vol 326, No. 19, Pages 1891-1983
https://jamanetwork.com/journals/jama/currentissue

Original Investigation
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
Laith J. Abu-Raddad, PhD; Hiam Chemaitelly, MSc; Houssein H. Ayoub, PhD; et al.
free access has active quiz
JAMA. 2021;326(19):1930-1939. doi:10.1001/jama.2021.19623
This cohort study assesses protection from SARS-CoV-2 breakthrough infection after mRNA vaccination among persons with vs without prior SARS-CoV-2 infection.

JAMA
November 16, 2021, Vol 326, No. 19, Pages 1891-1983
https://jamanetwork.com/journals/jama/currentissue

Changes in COVID-19 Vaccine Intent From April/May to June/July 2021
Peter G. Szilagyi, MD, MPH; Kyla Thomas, PhD; Megha D. Shah, MD, MPH, MS; et al.
free access
JAMA. 2021;326(19):1971-1974. doi:10.1001/jama.2021.18761
This study uses data from a nationally representative longitudinal study of adults in the US to examine individual-level change in vaccine intent and uptake between April and July 2021.

JAMA Network
COVID-19 Update November 20, 2021

These articles on COVID-19 were published across the JAMA Network in the last week.

Journal of Epidemiology & Community Health
November 2021 – Volume 75 – 11
https://jech.bmj.com/content/75/11

Social deprivation as a risk factor for COVID-19 mortality among women and men in the UK Biobank: nature of risk and context suggests that social interventions are essential to mitigate the effects of future pandemics (27 April, 2021)
Mark Woodward, Sanne A E Peters, Katie Harris

Journal of Epidemiology & Community Health
November 2021 – Volume 75 – 11
https://jech.bmj.com/content/75/11

Social inequalities
Indigenous Peoples, concentrated disadvantage, and income inequality in New Mexico: a ZIP code-level investigation of spatially varying associations between socioeconomic disadvantages and confirmed COVID-19 cases (23 March, 2021) Free
Kimberly R Huyser, Tse-Chuan Yang, Aggie J Yellow Horse

The Lancet
Nov 20, 2021 Volume 398 Number 10314 p1851-1938
https://www.thelancet.com/journals/lancet/issue/current

Articles
Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000–17: a financial modelling study
Gloria Ikilezi, Angela E Micah, Steven D Bachmeier, Ian E Cogswell, Emilie R Maddison, Hayley N Stutzman, Golsum Tsakalos, Logan Brenzel, Joseph L Dieleman
Open Access
Childhood immunisation is one of the most cost-effective health interventions. However, despite its known value, global access to vaccines remains far from complete. Although supply-side constraints lead to inadequate vaccine coverage in many health systems, there is no comprehensive analysis of the funding for immunisation. We aimed to fill this gap by generating estimates of funding for immunisation disaggregated by the source of funding and the type of activities in order to highlight the funding landscape for immunisation and inform policy making.

Nature
Volume 599 Issue 7885, 18 November 2021
https://www.nature.com/nature/volumes/599/issues/7885

Article | 21 September 2021
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Optimization of monoclonal antibodies against SARS-CoV-2 for enhanced Fc-effector function increase their effectiveness for prevention and treatment of COVID-19 in multiple animal models of SARS-CoV-2 infection.
Rachel Yamin, Andrew T. Jones, Stylianos Bournazos

Nature
Volume 599 Issue 7885, 18 November 2021
https://www.nature.com/nature/volumes/599/issues/7885

Article | 27 October 2021
A synthetic antibiotic class overcoming bacterial multidrug resistance
Structure-guided design and component-based synthesis are used to produce iboxamycin, a novel ribosome-binding antibiotic with potent activity against Gram-positive and Gram-negative bacteria.
Matthew J. Mitcheltree, Amarnath Pisipati, Andrew G. Myers

Nature Human Behaviour
Volume 5 Issue 11, November 2021
https://www.nature.com/nathumbehav/volumes/5/issues/11

Article | 17 May 2021
The natural selection of good science
Scientists fear that systemic incentives lead to poor science. Stewart and Plotkin use modelling to show how a scientific process emphasizing the use of theory to select hypotheses can allow good science to thrive in the face of pressure to publish.
Alexander J. Stewart, Joshua B. Plotkin

Nature Human Behaviour
Volume 5 Issue 11, November 2021
https://www.nature.com/nathumbehav/volumes/5/issues/11

Article | 13 October 2021
Science skepticism reduced compliance with COVID-19 shelter-in-place policies in the United States
Brzezinski et al. establish a link between science skepticism and compliance with COVID-19 shelter-in-place policies in the United States during March and April 2020. This relationship persists after controlling for political partisanship, socio-economic factors, income, education and COVID-19 prevalence.
Adam Brzezinski, Valentin Kecht, Austin L. Wright

Nature Human Behaviour
Volume 5 Issue 11, November 2021
https://www.nature.com/nathumbehav/volumes/5/issues/11

Article | 17 May 2021
Trust in science, social consensus and vaccine confidence
Trust in science is important for vaccine confidence, and this is true for countries as well as individuals. Sturgis et al. find that confidence in vaccination is higher in countries where people agree that scientists are trustworthy.
Patrick Sturgis, Ian Brunton-Smith, Jonathan Jackson

Nature Medicine
Volume 27 Issue 11, November 2021
https://www.nature.com/nm/volumes/27/issues/11

Diversity, Equity and Inclusion in medical research
In this issue, Nature Medicine is launching a Series on Diversity, Equity and Inclusion in medical research. The first installment brings a perspective on the role of funders in addressing the continued lack of diversity in science and medicine in the United States, and an overview of how governmental, societal and philanthropic stakeholders are approaching lack of diversity and inequalities in their research programs.

Nature Medicine
Volume 27 Issue 11, November 2021
https://www.nature.com/nm/volumes/27/issues/11

Editorial | 11 November 2021
Diversity, equity and inclusion: we are in it for the long run
We are launching a series on Diversity, Equity and Inclusion in medical research and are redoubling our commitment to representation in our pages.

Nature Medicine
Volume 27 Issue 11, November 2021
https://www.nature.com/nm/volumes/27/issues/11

Article | 30 September 2021
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
After two doses of the BNT162b2 vaccine, virus-specific antibodies and T cells were reduced in patients with solid tumors as compared to individuals without cancer, but neutralizing antibodies increased in most patients who received a third vaccine dose.
Rachna T. Shroff, Pavani Chalasani, Deepta Bhattacharya

Nature Medicine
Volume 27 Issue 11, November 2021
https://www.nature.com/nm/volumes/27/issues/11

Article | 09 September 2021 | Open Access
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
A randomized trial in patients hospitalized with COVID-19 showed no benefit and potentially increased harm associated with the use of convalescent plasma, with subgroup analyses suggesting that the antibody profile in donor plasma is critical in determining clinical outcomes.
Philippe Bégin, Jeannie Callum, Donald M. Arnold

Nature Medicine
Volume 27 Issue 11, November 2021
https://www.nature.com/nm/volumes/27/issues/11

Article | 15 September 2021 | Open Access
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
Preliminary and exploratory analyses show that a third dose of the COVID-19 vaccine mRNA-1273 or variant-modified boosters can boost levels of neutralizing antibodies against SARS-CoV-2 variants.
Angela Choi, Matthew Koch, Darin K. Edwards

Nature Medicine
Volume 27 Issue 11, November 2021
https://www.nature.com/nm/volumes/27/issues/11

Article | 29 September 2021 | Open Access
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Defined levels of SARS-CoV-2-specific binding and neutralizing antibodies elicited by the COVID-19 vaccine ChAdOx1 nCoV-19 are identified as correlates of protection against symptomatic infection.
Shuo Feng, Daniel J. Phillips, Christopher J. Williams

Nature Medicine
Volume 27 Issue 11, November 2021
https://www.nature.com/nm/volumes/27/issues/11

Article | 03 September 2021 | Open Access
Predictors of COVID-19 epidemics in countries of the World Health Organization African Region
A new study from the WHO African Region identifies features of countries that predict timing of the first case and the per capita mortality rate for the first and second waves of the COVID-19 epidemics.
Feifei Zhang, Humphrey Karamagi, Mark E. J. Woolhouse

New England Journal of Medicine
November 18, 2021 Vol. 385 No. 21
http://www.nejm.org/toc/nejm/medical-journal

Original Articles
Early Convalescent Plasma for High-Risk Outpatients with Covid-19F. K. Korley and Others

New England Journal of Medicine
November 18, 2021 Vol. 385 No. 21
http://www.nejm.org/toc/nejm/medical-journal

Editorials
Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates E.J. Rubin, L.R. Baden, M.M. Mello, and S. Morrissey

PLoS One
http://www.plosone.org/
[Accessed 20 Nov 2021]

Research Article
Influenza vaccination coverage among emergency department personnel is associated with perception of vaccination and side effects, vaccination availability on site and the COVID-19 pandemic
Anna-Maria Stöckeler, Philipp Schuster, Markus Zimmermann, Frank Hanses
Research Article | published 19 Nov 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0260213

PLoS One
http://www.plosone.org/
[Accessed 20 Nov 2021]

Evaluation of the United States COVID-19 vaccine allocation strategy
Md Rafiul Islam, Tamer Oraby, Audrey McCombs, Mohammad Mihrab Chowdhury, Mohammad Al-Mamun, Michael G. Tyshenko, Claus Kadelka
Research Article | published 17 Nov 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0259700

PLoS One
http://www.plosone.org/
[Accessed 20 Nov 2021]

COVID-19 vaccine uptake and hesitancy survey in Northern Ireland and Republic of Ireland: Applying the theory of planned behaviour
Gavin Breslin, Martin Dempster, Emma Berry, Matthew Cavanagh, Nicola C. Armstrong
Research Article | published 17 Nov 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0259381

PLoS One
http://www.plosone.org/
[Accessed 20 Nov 2021]

Individual determinants of COVID-19 vaccine hesitancy
Philip Gerretsen, Julia Kim, Fernando Caravaggio, Lena Quilty, Marcos Sanches, Samantha Wells, Eric E. Brown, Branka Agic, Bruce G. Pollock, Ariel Graff-Guerrero
Research Article | published 17 Nov 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0258462

PLoS One
http://www.plosone.org/
[Accessed 20 Nov 2021]

Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients
Dimitrios David Papazoglou, Oliver Baretella, Martin Feller, Cinzia Del Giovane, Elisavet Moutzouri, Drahomir Aujesky, Matthias Schwenkglenks, Denis O’Mahony, Wilma Knol, Olivia Dalleur, Nicolas Rodondi, Christine Baumgartner
Research Article | published 16 Nov 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0260112

PLoS One
http://www.plosone.org/
[Accessed 20 Nov 2021]

Can vaccination roll-out be more equitable if population risk is taken into account?
David R. Sinclair, Asri Maharani, Daniel Stow, Claire E. Welsh, Fiona E. Matthews
Research Article | published 15 Nov 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0259990

Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
https://www.paho.org/journal/en

19 Nov 2021
Communication products for COVID-19 prevention promoted by governments in Latin America and the Caribbean
Original research | Spanish |

Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
https://www.paho.org/journal/en

19 Nov 2021
Combined use of serologic markers and spatial analysis for epidemiological surveillance of leprosy
Original research | Portuguese

Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
https://www.paho.org/journal/en

19 Nov 2021
Timely initiation of HIV antiretroviral therapy in Haiti 2004–2018: a retrospective cohort study
Original research | English |